This momentum growth stock looks far too cheap

This growth stock is trading at a huge discount to net asset value.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

British Empire Trust (LSE: BTEM) flies under the radar of most investors because it’s not one of the market’s glamour stocks. However, over the past year, the £810m market cap trust has achieved staggering returns for investors, and it looks as if these returns are set to continue.

Explosive returns

Over the past 12 months, shares in closed-end investment trust have risen 44% as the enterprise’s net asset value (NAV) has expanded. According to the unaudited results for the half year ended 31 March 2017 published today, NAV increased by 15% compared to the previous period, to a high of 770.9p. Still, despite this rapid growth, the shares continue to trade at a discount to that value. At the end of the period, the value was 753p compared to the current market price of 678p. Year-on-year NAV has risen 39% from 544p.

Investment returns

The trust’s best-performing investment during the period was AP Alternative Assets, which helped add 3.53% to NAV by its value increasing 48% on a dollar basis. This massive gain was driven by the long-awaited IPO of Athene Insurance — the sole asset owned by AP Alternative — that came at a premium to its carrying value.

The trust first invested in AP back in 2012 and the asset has generated an outstanding return since the initial investment. The internal rate of return over the past five years is 55% per annum. Now the IPO of Athene has been completed, British Empire has reduced its holding in AP but continues to see upside in the publicly traded insurance company.

The trust’s second largest contributor during the period was JPEL Private Equity. Like AP, JPEL has achieved some impressive returns on its investments, which have in turn led to substantial profits for British Empire.

After the sale of two substantial businesses from the JPEL portfolio (both of which achieved internal rates of return of 50% or more) JPEL was able to return 19% of its NAV to investors.

Management success

With any investment trust, it’s always difficult to assess whether or not the investment managers in charge have enough investment skill to be able to produce lucrative returns for investors. British Empire’s management looks as if it ticks this box.

By outsourcing capital to experienced private equity businesses, the trust has been able to achieve market-beating returns and shareholders have reaped the rewards. Almost all of the assets owned by the trust are private equity businesses acquired when trading at a discount to NAV. This shows British Empire’s management has shareholder interests at heart and is unlikely to overpay for assets.

As the trust continues with this investment strategy NAV should only increase, and management is trying to reduce the trust’s trading discount to NAV via an ongoing share buyback programme — another sensible capital allocation decision.

The bottom line

So overall, as British Empire continues to reap the rewards from its private equity investments, shares in the trust look as if they can head much higher from current levels. This is one undervalued growth stock you might not want to miss.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »